Published in Medical Letter on the CDC and FDA, May 22nd, 2005
The scientists developed disease models using yeast and successfully introduced five mutations that make malaria resistant to the antimalarial drug atovaquone. The study, featured in Journal of Biological Chemistry, paves the way for using these models to test new drugs that could suppress malaria's ability to mutate against current therapy.
"This is the first quantitative explanation for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA